Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
UBS
Teva
Cipla
Julphar
Chinese Patent Office
Mallinckrodt
Moodys
Argus Health
Queensland Health

Generated: October 21, 2017

DrugPatentWatch Database Preview

CELEBREX Drug Profile

« Back to Dashboard

Which patents cover Celebrex, and what generic Celebrex alternatives are available?

Celebrex is a drug marketed by Gd Searle and is included in one NDA.

The generic ingredient in CELEBREX is celecoxib. There are twenty-six drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the celecoxib profile page.

Summary for Tradename: CELEBREX

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list26
Bulk Api Vendors: see list87
Clinical Trials: see list110
Patent Applications: see list7,013
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CELEBREX at DailyMed

Pharmacology for Tradename: CELEBREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-004Dec 15, 2006ABRXYesNo► Subscribe► Subscribe► Subscribe
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-003Aug 29, 2002ABRXYesYes► Subscribe► Subscribe► Subscribe
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-001Dec 31, 1998ABRXYesNo► Subscribe► Subscribe► Subscribe
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-002Dec 31, 1998ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CELEBREX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-001Dec 31, 1998► Subscribe► Subscribe
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-003Aug 29, 2002► Subscribe► Subscribe
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-003Aug 29, 2002► Subscribe► Subscribe
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-004Dec 15, 2006► Subscribe► Subscribe
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-001Dec 31, 1998► Subscribe► Subscribe
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-003Aug 29, 2002► Subscribe► Subscribe
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-002Dec 31, 1998► Subscribe► Subscribe
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-004Dec 15, 2006► Subscribe► Subscribe
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-003Aug 29, 2002► Subscribe► Subscribe
Gd Searle
CELEBREX
celecoxib
CAPSULE;ORAL020998-002Dec 31, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for CELEBREX

Drugname Dosage Strength RLD Submissiondate
celecoxibCapsules50 mgCelebrex3/21/2008
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Medtronic
Express Scripts
US Army
Baxter
Farmers Insurance
Covington
Daiichi Sankyo
Cipla
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot